Argenica strengthens the clinical case for neuroprotective drug candidate ARG-007 with new independently generated preclinical stroke data. ... Read More The post New preclinical study validates ...

Jeremy has more than 2100 published articles on Collider to his name, and has been writing for the site since February 2022. He's an omnivore when it comes to his movie-watching diet, so will gladly ...

We'll highlight a different cause every week. ‘That Has Never Been Tolerated in the Entire History of Our Republic’ Warren Buffett suggests all parents do one thing before they die, whether they have ...

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics ("MoonLake" or the "Company") (NASDAQ: MLTX) of a class action securities lawsuit.

SAO PAULO (AP) — Just days ahead of the U.N. climate conference to be held in Brazil, a group of 300 mayors gathered Monday in Rio de Janeiro to pledge coordinated climate action and address rising ...

A team of organic and computational chemists at the University of Minnesota Twin Cities have created a new, modern tool to ...

Inhibitory receptors have increasingly been recognized as critical players in the maintenance of immune homeostasis. These receptors, expressed on a variety ...